GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Corp (NYSE:MCK) » Definitions » Piotroski F-Score

MCK (McKesson) Piotroski F-Score : 6 (As of Dec. 12, 2024)


View and export this data going back to 1987. Start your Free Trial

What is McKesson Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

McKesson has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for McKesson's Piotroski F-Score or its related term are showing as below:

MCK' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 8
Current: 6

During the past 13 years, the highest Piotroski F-Score of McKesson was 8. The lowest was 4. And the median was 6.


McKesson Piotroski F-Score Historical Data

The historical data trend for McKesson's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Piotroski F-Score Chart

McKesson Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 5.00 7.00 7.00 5.00

McKesson Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 5.00 5.00 6.00 6.00

Competitive Comparison of McKesson's Piotroski F-Score

For the Medical Distribution subindustry, McKesson's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson's Piotroski F-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where McKesson's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was 589 + 791 + 915 + 241 = $2,536 Mil.
Cash Flow from Operations was 254 + 4147 + -1380 + 2100 = $5,121 Mil.
Revenue was 80898 + 76355 + 79283 + 93651 = $330,187 Mil.
Gross Profit was 3152 + 3585 + 3152 + 3248 = $13,137 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(66091 + 66512 + 67443 + 71670 + 72429) / 5 = $68829 Mil.
Total Assets at the begining of this year (Sep23) was $66,091 Mil.
Long-Term Debt & Capital Lease Obligation was $6,923 Mil.
Total Current Assets was $53,341 Mil.
Total Current Liabilities was $58,771 Mil.
Net Income was 1079 + 787 + 958 + 664 = $3,488 Mil.

Revenue was 70490 + 68910 + 74483 + 77215 = $291,098 Mil.
Gross Profit was 3174 + 3066 + 3022 + 3069 = $12,331 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(63081 + 62690 + 62320 + 64096 + 66091) / 5 = $63655.6 Mil.
Total Assets at the begining of last year (Sep22) was $63,081 Mil.
Long-Term Debt & Capital Lease Obligation was $6,971 Mil.
Total Current Assets was $47,531 Mil.
Total Current Liabilities was $51,147 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

McKesson's current Net Income (TTM) was 2,536. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

McKesson's current Cash Flow from Operations (TTM) was 5,121. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=2536/66091
=0.03837134

ROA (Last Year)=Net Income/Total Assets (Sep22)
=3488/63081
=0.05529399

McKesson's return on assets of this year was 0.03837134. McKesson's return on assets of last year was 0.05529399. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

McKesson's current Net Income (TTM) was 2,536. McKesson's current Cash Flow from Operations (TTM) was 5,121. ==> 5,121 > 2,536 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=6923/68829
=0.1005826

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=6971/63655.6
=0.10951118

McKesson's gearing of this year was 0.1005826. McKesson's gearing of last year was 0.10951118. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=53341/58771
=0.90760749

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=47531/51147
=0.92930182

McKesson's current ratio of this year was 0.90760749. McKesson's current ratio of last year was 0.92930182. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

McKesson's number of shares in issue this year was 129.3. McKesson's number of shares in issue last year was 134.8. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=13137/330187
=0.03978655

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=12331/291098
=0.0423603

McKesson's gross margin of this year was 0.03978655. McKesson's gross margin of last year was 0.0423603. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=330187/66091
=4.99594498

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=291098/63081
=4.61467003

McKesson's asset turnover of this year was 4.99594498. McKesson's asset turnover of last year was 4.61467003. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

McKesson has an F-score of 6 indicating the company's financial situation is typical for a stable company.

McKesson  (NYSE:MCK) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


McKesson Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of McKesson's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Business Description

Address
6555 State Highway 161, Irving, TX, USA, 75039
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Executives
Brian S. Tyler officer: Chief Executive Officer MCKESSON CORPORATION, 6555 STATE HWY 161, IRVING TX 75039
Leann B Smith officer: EVP & Chief HR Officer 6555 NORTH STATE HWY 161, IRVING TX 75039
Maria Martinez director THE LANDMARK @ 1 MARKET STREET, SUITE 300, SAN FRANCISCO CA 94105
Thomas L Rodgers officer: EVP, Chief Strategy & BDO 6555 NORTH STATE HWY 161, IRVING TX 75039
Britt J. Vitalone officer: EVP & CFO MCKESSON CORPORATION, 6555 STATE HWY 161, IRVING TX 75039
Susan Nowakowski director 14778 EL RODEO CT., RANCHO SANTA FE CA 92067
Rutledge Napoleon B Jr officer: SVP, Controller & CAO 2999 WILDWOOD PARKWAY, ATLANTA GA 30339
Lori A. Schechter officer: EVP, Chief Legal Officer & GC MCKESSON CORPORATION, 6555 NORTH STATE HWY 161, IRVING TX 75039
Nancy Flores officer: EVP, CIO & CTO 6555 NORTH STATE HWY 161, IRVING TX 75039
Tracy Faber officer: EVP & Chief HR Officer 6555 NORTH STATE HWY 161, IRVING TX 75039
Donald R Knauss director P O BOX 1734, ATLANTA GA 30301
Bradley E Lerman director MEDTRONIC, INC., 710 MEDTRONIC PKWY MSLC300, MINNEAPOLIS MN 55432
Dominic J Caruso director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Webster Roy Dunbar director 5757 N. GREEN BAY AVENUE, MILWAUKEE WI 53209
James H. Hinton director 6555 NORTH STATE HWY. 161, IRVING TX 75039